Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

AUTL Autolus Therapeutics

Watchlist
2.230
+0.230+11.50%
Close  02/08 16:00 ET
2.290
+0.060+2.69%
Pre Mkt Price 02/09 07:00 ET
High
2.310
Open
1.970
Turnover
6.60M
Low
1.970
Pre Close
2.000
Volume
3.03M
Market Cap
385.92M
P/E(TTM)
Loss
52wk High
4.730
Shares
173.06M
P/E(Static)
Loss
52wk Low
1.600
Float Cap
181.20M
Bid/Ask %
-84.00%
Historical High
53.240
Shs Float
81.26M
Volume Ratio
8.33
Historical Low
1.600
Dividend TTM
--
Div Yield TTM
--
P/B
2.40
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
3.73%
Amplitude
17.00%
Avg Price
2.179
Lot Size
1
Float Cap
181.20M
Bid/Ask %
-84.00%
Historical High
53.240
Shs Float
81.26M
Volume Ratio
8.33
Historical Low
1.600
Dividend TTM
--
P/B
2.40
Dividend LFY
--
Turnover Ratio
3.73%
Amplitude
17.00%
Avg Price
2.179
Lot Size
1
Price Forecast

News

Comment

Company Overview More
Autolus Therapeutics Plc is a biopharmaceutical company, which engages in the development and commercialization of gene therapies. It uses proprietary and modular T cell programming technologies that are designed to recognize cancer cells, break down their defense mechanisms, and attack and kill these cells. The company was founded by Martin Pule in September 2014 and is headquartered in London, the United Kingdom.
CEO: Dr. Christian Itin, PhD.
Market: NASDAQ
Listing Date: 06/22/2018
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist